Efficacy of Intraoperative Brimonidine for Hemostasis During Eyelid Surgery

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The purpose of this study is to observe and report the effects of topical ophthalmic brimonidine in oculofacial plastic surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: Accepts Healthy Volunteers
View:

• Above the age of 18

• Ophthalmic conditions requiring oculoplastic surgery

Locations
United States
Kentucky
University of Louisville
Recruiting
Louisville
Contact Information
Primary
Christopher Compton, MD
christopher.compton@louisville.edu
5025880550
Backup
Jeremy Clark, MD
jeremy.clark.3@louisville.edu
5025880550
Time Frame
Start Date: May 26, 2022
Estimated Completion Date: December 30, 2022
Participants
Target number of participants: 100
Treatments
Experimental: Brimonidine intervention
We will compare hemostasis between 2 surgical sides of the same patient. One side will be randomized to receive Brimonidine (0.15% or 0.2%) in addition to standard hemostasis measures, while the other side will receive only standard hemostasis measures (preoperative discontinuation of blood thinners, preoperative injection of lidocaine with epinephrine).
No Intervention: Control Arm
We will compare hemostasis between 2 surgical sides of the same patient. One side will be randomized to receive Brimonidine (0.15% or 0.2%) in addition to standard hemostasis measures, while the other side will receive only standard hemostasis measures (preoperative discontinuation of blood thinners, preoperative injection of lidocaine with epinephrine).
Authors
Julia Elpers, Christopher Compton
Sponsors
Leads: University of Louisville

This content was sourced from clinicaltrials.gov

Similar Clinical Trials